Will stopping aripiprazole (Abilify) stop the akathisia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, stopping Abilify will likely stop the akathisia.

Discontinuing aripiprazole is the definitive treatment for aripiprazole-induced akathisia, and symptoms typically resolve completely after discontinuation 1, 2. Multiple case reports demonstrate complete remission of akathisia following aripiprazole cessation 3, 1, 2, 4.

Key Evidence Supporting Discontinuation

The FDA label clearly identifies akathisia as a common adverse reaction to aripiprazole, occurring in 10-13% of adults with bipolar mania and 10-25% of patients with major depressive disorder receiving adjunctive therapy 5. When akathisia occurs, it represents a drug-induced adverse effect that is directly attributable to aripiprazole's mechanism of action.

Given aripiprazole's long elimination half-life (approximately 75 hours), the medication can be stopped abruptly without tapering—it will "auto-taper" naturally 6. This is a significant practical advantage when managing distressing akathisia.

Clinical Course After Discontinuation

  • Onset of akathisia: Typically occurs early in treatment (within the first few weeks) 7
  • Resolution timeline: Symptoms resolve after discontinuation, though the exact timeframe depends on the drug's elimination (may take 1-2 weeks given the long half-life)
  • Severity: While akathisia is generally mild-to-moderate 7, it can be severe and associated with significant distress, anxiety, and even suicidal ideation 1, 4

Important Clinical Considerations

Akathisia can be severely distressing and is associated with treatment discontinuation in clinical practice 1, 4. The 2026 ASCP deprescribing guidelines emphasize that when adverse effects unequivocally outweigh benefits, discontinuation is appropriate 6. Akathisia with associated distress, anxiety, or suicidal thoughts clearly meets this threshold 1, 4.

Common Pitfalls to Avoid:

  1. Do not add propranolol while continuing aripiprazole: While beta-blockers are traditionally used to treat akathisia, propranolol inhibits CYP2D6 and can increase aripiprazole levels, potentially worsening akathisia 8

  2. Monitor for complete resolution: Ensure symptoms fully resolve after discontinuation to confirm the diagnosis

  3. Consider alternative antipsychotics if needed: If antipsychotic treatment is still required, switching to an agent with lower akathisia risk may be necessary

Risk Factors Worth Noting

  • Rapid dose escalation increases akathisia risk with some antipsychotics 9
  • Combination with lamotrigine and antidepressants may worsen akathisia 4
  • Low starting doses are recommended when initiating aripiprazole in patients with mood disorders 4

The bottom line: Stop the aripiprazole. The akathisia will resolve. No taper is required due to the medication's pharmacokinetic properties 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.